ClinVar Miner

Submissions for variant NM_012388.4(BLOC1S6):c.200C>G (p.Ser67Ter)

dbSNP: rs772475341
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratoire de Génétique Moléculaire, CHU Bordeaux RCV001027539 SCV001162834 likely pathogenic Hermansky-Pudlak syndrome 9 2020-02-20 criteria provided, single submitter clinical testing Patient is having oculocutaneous albinism and severe defect of platelets dense bodies highly suggesting of Hermansky-Pudlak Syndrome. Variant in trans of another variant classified Likely Pathogenic upon ACMG classification. Each parent has one variant.
Invitae RCV001027539 SCV002965327 pathogenic Hermansky-Pudlak syndrome 9 2023-10-19 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ser67*) in the BLOC1S6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLOC1S6 are known to be pathogenic (PMID: 10610180, 21665000, 22461475). This variant is present in population databases (rs772475341, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 32245340). ClinVar contains an entry for this variant (Variation ID: 827680). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.